MARKET

ANIP

ANIP

Ani Pharmaceutic
NASDAQ
77.36
+0.66
+0.86%
After Hours: 77.00 -0.36 -0.47% 18:13 02/13 EST
OPEN
76.80
PREV CLOSE
76.70
HIGH
79.13
LOW
76.10
VOLUME
279.30K
TURNOVER
--
52 WEEK HIGH
99.50
52 WEEK LOW
54.10
MARKET CAP
1.74B
P/E (TTM)
47.44
1D
5D
1M
3M
1Y
5Y
1D
ANI Pharmaceuticals Inc. to Announce Fourth Quarter and Full Year Financial Results
Reuters · 1d ago
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026, at 8:00 a.m. ET
Barchart · 1d ago
Weekly Report: what happened at ANIP last week (0202-0206)?
Weekly Report · 5d ago
Weekly Report: what happened at ANIP last week (0126-0130)?
Weekly Report · 02/02 09:29
Weekly Report: what happened at ANIP last week (0119-0123)?
Weekly Report · 01/26 09:29
1 Cash-Producing Stock on Our Buy List and 2 We Brush Off
Barchart · 01/26 03:20
MRNA is S&P 500’s top performing stock, here are the best Quant pharma companies
Seeking Alpha · 01/21 19:36
Analysts Offer Insights on Healthcare Companies: ANI Pharmaceuticals (ANIP), Abeona Therapeutics (ABEO) and Akebia Therapeutics (AKBA)
TipRanks · 01/21 15:40
More
About ANIP
ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company engaged in developing, manufacturing, and commercializing therapeutics. Its Rare Disease and Brands segment consists of two reporting units. The Rare Disease unit consists of operations related to the development, manufacturing, and marketing of branded pharmaceutical products, with a focus on products used in the treatment of patients with rare disease conditions and consists of operations related to Cortrophin Gel, ILUVIEN and YUTIQ. In addition, the Brands reporting unit includes a portfolio of over 16 brand products that are principally sold in genericized markets. Its Generics and Other segment consist of operations related to the development, manufacturing, and marketing of generic pharmaceutical products, including those sold through traditional wholesale and retail sales channels, sales of contract manufactured products, royalties on contract manufactured products, product development services, and others.

Webull offers ANI Pharmaceuticals Inc stock information, including NASDAQ: ANIP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANIP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ANIP stock methods without spending real money on the virtual paper trading platform.